|  |
Category: Main/Drug Safety & WarningsKeywords: Drug safety alerts and warnings, adverse drug reaction warning, medical alerts, FDA drug warnings, drug warning
Sort Links by: Title / Popularity
Links currently sorted by: Popularity (Most to least hits)
Australian Adverse Drug Reactions Bulletin
This site provides access to the articles of the Australian Adverse Drug Reactions Bulletin published by the TGA (Therapeutic Goods Administration). (Free access to articles).
WHO Pharmaceuticals Newsletter
The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from WHO's network of 'drug information officers,' and other sources such as specialized bulletins and journals.
WHO Drug Alerts
WHO issues a rapid Drug alert whenever a serious problem in the safety of any medicinal product arises.
Canadian Adverse Reaction Reporting & Newsletter
Alerts health professionals to adverse reactions reported in Canada. Procedures to follow in reporting adverse drug reactions.
ISMP Medication Safety Alert - US
Institute for Safe Medication Practices
Monitoring the safety and quality of medicines
UK government site.
US-FDA MedWatch - Medical Product Safety Information
Reports on the safety alerts, recalls, withdrawals, and important labeling changes regarding medical products
US-FDA Center for Drug Evaluation and Research (CDER)
Drug Eruption Global Database
Subscription required. Fully referenced, comprehensive, constantly updated database identifying which prescription medicines, OTC drugs and herbal therapies can cause any of the wide range of known adverse dermatological drug reactions
ISMP - Canada
Institute for Safe Medication Practices Canada
European Agency for the Evaluation of Medicinal Products (EMEA)
The constant monitoring of the safety of medicines after authorisation (‘pharmacovigilance’) is an important part of the work of the national competent authorities and EMEA. The EMEA receives safety reports from within the EU and outside concerning centrally authorised medicinal products and coordinates action relating to the safety and quality of medicinal products.
Swedish Medical Products Agency (MPA)
MPA is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and sale of drugs and other medical products. Its task is to ensure that both the individual patient and healthcare professionals have access to safe and effective products and that these are used in a rational and cost-effective manner.
Medical Errors & Patient Safety - Agency for Healthcare Research and Quality (AHRQ)
This AHRQ site is a major U.S. Federal initiative that has been launched to reduce medical errors and improve patient safety in federally funded health care programmes and in the private sector. It provides links to information that can be found in documents, press releases, patient safety task forces, the quality interagency coordination task force (QuIC), workshops, speeches and statements, and congressional hearings, all related to medical errors.
New Zealand Medicines and Medical Devices Safety Authority (Medsafe)
Medsafe is the New Zealand Medicines and Medical Devices Safety Authority. It is a business unit of the Ministry of Health and is the authority responsible for the regulation of therapeutic products in New Zealand. Medsafe's mission is to enhance the health of New Zealanders by regulating medicines and medical devices to maximise safety and benefit.
Medicines and Healthcare products Regulatory Agency
UK resources
Adverse Drug Reaction Reporting
From West Midlands Centre for Adverse Drug Reaction Reporting
Center for Adverse Drug Monitoring - New Zealand
New Zealand Pharmacovigilance Centre
European Medicines Agency Drug Safety Warnings
European resources. Include human as well veterinary medicines
Uppsala Monitoring Centre - WHO
WHO Collaborating Centre for International Drug Monitoring
|
|
|
|
